Think Big, Start Small: How Nanomedicine Could Alleviate the Burden of Rare CNS Diseases
The complexity and organization of the central nervous system (CNS) is widely modulated by the presence of the blood–brain barrier
Tag: BBB
Global Conference on Pharmaceutics and Drug Delivery Systems (PDDS 2021),
“4th Edition of Global Conference on Pharmaceutics and Drug Delivery Systems” (PDDS 2021) is going to be held during September
Cyclo Therapeutics Meets Primary Efficacy Endpoint in Phase 1/2 Trial from Intravenous Trappsol® Cyclo™ in Rare Disease Niemann-Pick Type C1 (NPC1)
100% of patients who completed the trial improved or remained stable, and 89% met the efficacy outcome measure of improvement
Cyclolab and EpiPharma Form Joint Venture company Targetrin Therapeutics to Develop and Commercialize novel conjugated Cyclodextrin – Peptide drugs
Cyclolab, the oldest, world renowned cyclodextrin research, development and manufacturing company, and EpiPharma, a bio-pharmaceutical services and peptide drug development
Cyclodextrin News Year in Review 2018
The CDNews blog was created in July and after a short period of trial it started in September. During this
NO-releasing cyclodextrins
Nitric oxide (NO) is a signaling molecule produced by almost all types of organisms ranging from bacteria to plants and
Therapeutic potential for cyclodextrin‐based macromolecular systems in NPC
A paper has just come out in Macromolecular Rapid Communications highlighting the potential benefits of cyclodextrin-based macromolecular systems as cholesterol-mopping
Different cyclodextrins to treat NPC
If you are following advances in the re-discovery of cyclodextrins as APIs, there is quite a race among the candidates
Advancements of CD analysis in Niemann-Pick C
Clearly, understanding the mechanism of action for cyclodextrins and consequently finding the most appropriate canditate for the treatment of Niemann
HPαCD More Effective than HPβCD Against Breast Cancer
Wittkowski et al. recently published their results on re-evaluation of three genome-wide association studies using computational biostatistics approach. The genetic